Neurodoron® for Stress Impairments: A Prospective, Multicenter Non-Interventional Trial

Figure 4

Subjective assessment of the efficacy and tolerability of Neurodoron® at study end (N = 174); assessment options: “very good,” “good,” “satisfactory,” “unsatisfactory,” and “I do not know.”